Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
YRCW is on a tear with big buys coming in now @ HOD. Could be a huge gapper tomorrow.
SPPI was trading under $2 back in April and ran up to this level in anticipation of FDA approval. Profit taking was expected with many holding on to huge paper profits leading up to this FDA decision (the ole' buy the rumor, sell the news).
With that said "SPPI has yet another drug that will be reviewed by the FDA, Fusilev®, on October 8th. Here, SPPI is seeking to get Fusilev approved for use in combination with 5FU for the treatment of colorectal cancer. Fusilev is already approved in the US for combination treatment of osteosarcoma.
It should be noted that it is very rare for a small cap drug maker to have two drugs reviewed in one year. From my research, I could not find another drug maker who had previously received approval for two cancer drugs in the same year. SPPI is very rare case and is worth paying some attention.
Odds of successful outcome: 85%"
Once SPPI consolidates in the low $8's, I expect a run up to $10+ leading up to the 10/8 FDA decision on Fusilev®.
AJMHO & GLTU
"The Worst of All Worlds": Don't Believe the Recovery Hype, Ortel Says
Posted Sep 03, 2009 10:30am EDT by Aaron Task in Investing, Recession
Enjoy the last days of summer and the Labor Day holiday because there is "abundant cause for concern," says Charles Ortel, managing director of Newport Value Partners, an independent research firm.
A self-described optimist, Ortel nevertheless says the "worst of all worlds" is coming, characterized by falling asset prices and higher taxes, accompanied by a rising cost of core goods and services. Echoing the "stagflation" of the 1970s, he has coined the term "skew-flation" to describe what's ahead.
As to growing consensus the global economy is on the mend, Ortel believes both government "macro" data and corporate "micro" data are painting a much rosier picture vs. actual reality. The real macro story, he says, is there's too much productive capacity around the world and not enough demand. At the same time, private sector incomes are down while debt levels are up.
"We are still in the middle of systemic shock" and emergency government programs have temporarily kept the global economy on "life support," he says. "We think governments have little additional room left to continue to postpone the restructuring that's necessary around the world."
Other causes for concern include:
A pending commercial real estate "meltdown" that will subject the banking system to another round of big losses.
A true accounting for the costs of government bailouts to date, even as state and local governments face a massive crisis of their own. He believes a day of reckoning is coming where foreigners will refuse to fund America's runaway deficits at today's very low rates.
It's impossible to say when these issues manifest themselves in the market but Ortel says, yes, investors should beware the ides of September-October.
http://finance.yahoo.com/tech-ticker/article/316690/%22The-Worst-of-All-Worlds%22-Don
Don't you mean during that 12 minute trading break on the toilet? j/k :)
Yup...
Acadia psychosis drug misses main goal; shrs sink
Drug misses antipsychotic efficacy goal
* Acadia co-developing the drug with Biovail
* Acadia shares sink 68 pct; Biovail down 2 pct (Adds analyst comment, bylines; updates shares)
By Lewis Krauskopf and Ransdell Pierson
NEW YORK, Sept 1 (Reuters) - Acadia Pharmaceuticals Inc (ACAD.O) said on Tuesday its experimental drug for psychosis related to Parkinson's disease failed to meet its primary goal in a late-stage trial, sending its shares down 68 percent.
The drug, pimavanserin, which is being co-developed with Canada's Biovail Corp (BVF.TO), failed to significantly cut psychotic episodes, such as hallucinations and delusions, compared with a placebo.
The steep drop in Acadia shares illustrates the risks in biotech investing, after a number of high-profile clinical successes this year have sent shares of several companies soaring.
As of Monday, shares of Acadia had run up nearly sixfold since late April to $5.84 on hopes for pimavanserin, the company's lead experimental product. The shares fell to $1.86 in morning trading Tuesday. Shares of Biovail were down 2 percent in Toronto.
An estimated 600,000 of the 1.5 million Americans with Parkinson's disease are prone to psychotic episodes, according to Acadia. Parkinson's is a progressive neurological condition that causes tremors and other motor skills problems.
Patients in the 298-patient trial who were taking pimavanserin showed improvement in psychosis measures, but the difference was not statistically significant. Acadia said the lack of a significant difference was primarily due to the larger-than-expected improvement in patients taking the placebo.
The trial did reach a secondary goal related to motor function. San Diego-based Acadia said it was continuing with a second Phase III clinical trial with pimavanserin in patients with Parkinson's disease psychosis.
"While we obviously are disappointed with the results of this Phase III study, we continue to believe in the potential of pimavanserin based on our clinical experience to date," Acadia Chief Executive Officer Uli Hacksell said in a statement.
In an interview with Reuters last month, Hacksell said pimavanserin could fetch far bigger sales if it is eventually approved to treat other types of psychosis, including psychosis that often accompanies Alzheimer's disease.
Citigroup on Tuesday cut its rating on Acadia to "sell" from "hold," citing the trial failure.
But JMP Securities analyst Charles Duncan said it may be too early to write pimavanserin's epitaph.
"Acadia will do additional analyses over the next month and will then tell us whether they will alter the ongoing Phase III study in Parkinson's disease psychosis, and whether they'll start (trials) in Alzheimer's psychosis," Duncan said. Continued...
Took a starter in ACAD @ 1.92. It's already traded the full float this morning. Looking for a decent bounce back to the $2's.
Interesting post from Yahoo....
http://messages.finance.yahoo.com/Stocks_%28A_to_Z%29/Stocks_C/threadview?m=tm&bn=51272&tid=93055&mid=93055&tof=4&frt=2
There was tension between the fed, treasury, and fdic when talks were going on. The fed and treasury wanted to give access to the fed window and guaranty debt. It was actually leaked. I am sure some of you saw the news released on cnbc the evening before the fdic pulled out. Sheila Bair put her foot down and ceased talks. Dialogue amongst the powers to be have had a meeting of the minds due to the damage of a CIT bankruptcy could have on the recovering economy.
How do you resume talks without eating crow? Heres how:
You reengage under the NY feds term thus the agreement. The FDIC was not happy about the terms of the bondholder agreement. They realized they should have given access to the fed window to begin with. There is no way of getting a lower cost of funds without the same borrowing as banks. If the fed window is not going to be offered, this whole restructuring plan would be moot! Mark my words the fed window news will come out within the next couple of days. Why you ask:
to settle their customers so they do not continue to make unnecessary draw downs
it was stated that the health of the holding company is a common goal between cit and the NY fed, thus they are simply looking at projections of what the profitability will be in 2010 with fed funds available. They will be very profitable with that.
This stock is going to rise fast and furious very soon! For the sake of full disclosure i have been accumulating over the past few weeks and hold a large quantity of shares. In response to the shorts, i do sleep well at night.
I sure as heck would not want to be short when this news hits the wires and I am confident that it will soon....
GLTA
Interesting post on Yahoo re BEE (I happen to agree and think that we have a winner here with huge upside potential):
http://messages.finance.yahoo.com/Stocks_%28A_to_Z%29/Stocks_S/threadview?m=tm&bn=27723&tid=3243&mid=3243&tof=1&frt=2
"BEE is down due to the short term liquidity problem. Even with Swine Flu and recession they are close to being breakeven on EBITDA.
Since FED is stuck on monetizing our way out of the problem it is very likely that the USD will go down.
This scenario plays well into BEE's hands. Half of the portfolio is outside of US and several properties in Europe will appreciate considerably in USD terms.
AS USD deteriorates their asset base will go up in value and the equity portion of the company will go up substantialy.
I can see BEE's stock price in teens within 2 years in this scenario. FED is working in BEE's favor..
Add in business improvement and you have a winner here."
Re BEE: I also like the fact that Vector Group LTD took a 7.1% stake in BEE, a couple of months ago, all the way up to $1.74/share.
http://www.sec.gov/Archives/edgar/data/5...
No. of Shares Price Per
Name Date Purchased Share (1)
Vector Group Ltd. 6/10/2009 100 1.6299
Vector Group Ltd. 6/10/2009 31,400 1.6300
Vector Group Ltd. 6/10/2009 400 1.6398
Vector Group Ltd. 6/10/2009 8,665 1.6400
Vector Group Ltd. 6/10/2009 100 1.6450
Vector Group Ltd. 6/10/2009 30,100 1.6500
Vector Group Ltd. 6/10/2009 7,000 1.6600
Vector Group Ltd. 6/10/2009 800 1.6700
Vector Group Ltd. 6/10/2009 1,300 1.6800
Vector Group Ltd. 6/10/2009 5,300 1.7000
Vector Group Ltd. 6/10/2009 2,769 1.7100
Vector Group Ltd. 6/10/2009 931 1.7200
Vector Group Ltd. 6/10/2009 3,900 1.7300
Vector Group Ltd. 6/10/2009 1,200 1.7350
Vector Group Ltd. 6/10/2009 200 1.7398
Vector Group Ltd. 6/10/2009 6,800 1.7400
That bodes well for us. The entire travel sector has been bouncing off lows lately (and BEE has not participated in the rally). I think that's about to change. Looking for $2+ in the coming days.
From Goldman Sachs on lodging:
We believe the path to higher lodging stock prices is getting increasingly clear for the following reasons: (1) Monthly RevPAR trends are starting to get “less bad” moving from negative 20% in May to negative 16% in July and comparisons get easier from here; (2) the supply story continues to
get better with the number of rooms under construction down 27% yoy and the pipeline is at a three year low; (3) expense reductions have been so dramatic that even a modest pick up in RevPAR should lead to outsized profit gains; and (4) there is a scarcity of Lodging large cap ways to invest
in the rebound and a potential for a shift away from the prevailing bearish sentiment.
NEP ready for a big move here. Low floater China O&G play making .92/share trailing earnings and only trading for $6. Extremely undervalued compared to it's peers.
This news out of China should also drive NEP much higher...
Bloomberg: China Buys Record Oil, Iron Ore Volumes as Plants Lift Output
China Buys Record Oil, Iron Ore Volumes as Plants Lift Output
China bought record volumes of oil and iron ore in July as automakers, steel producers and builders expanded output to meet rising demand driven by the nation's $586 billion stimulus spending. Oil imports jumped 18 percent to 19.6 million metric tons, and iron ore purchases rose 5 percent to 58.1 million tons from a month ago, the Beijing-based customs said today in a statement on its Web site. The second-largest energy user and biggest iron ore buyer spent a combined $13.8 billion on the commodities. Record lending and public-work spending in China have lifted industrial output, boosted sales at General Motors Co. and spurred a 60 percent jump in property sales. The nation's biggest refiners will boost diesel and gasoline output this month to meet demand from the auto and fishing industries, said China Petrochemical Corp., also known as Sinopec Group. "This is a very bullish number and supportive for global oil prices," said Gordon Kwan, head of regional energy research at Mirae Asset Securities Ltd. "Successive months of robust automobile sales following the implementation of the economic stimulus measures," is triggering the oil import boom, he said. Crude steel production in China, the world's biggest maker, surged 13 percent last month to 50.7 million tons, the National Bureau of Statistics also said today at a briefing in Beijing. That's the third consecutive record monthly high, according to Bloomberg data. Iron ore is used in steelmaking. "Iron ore restocking pushed up the imports and prices as the stimulus package drives up steel demand," said Helen Wang, a Shanghai-based analyst with DBS Vickers Hong Kong Ltd., "Steelmakers have the motivation to ramp up production with higher steel prices. "Benchmark Chinese steel prices have soared 30 percent since April, and Baosteel Group Corp., China's largest steelmaker, can't meet "explosive" demand, JPMorgan Chase & Co. said last week. The steel revival has hampered China's ability to bargain down iron ore prices paid to Rio Tinto Group, Vale SA and BHP Billiton Ltd., and indicates imports of the raw material will keep rising. (Bloomberg)
I'm liking NEP more and more down here @ $6, especially in light of the news out yesterday regarding "China buying record amounts of oil and iron ore".
With NEP's low float (29M OS) and oil expected to move back to $100/barrel seems like a no-brainer doubler in the coming weeks/months IMHO.
Bloomberg: China Buys Record Oil, Iron Ore Volumes as Plants Lift Output
China Buys Record Oil, Iron Ore Volumes as Plants Lift Output
China bought record volumes of oil and iron ore in July as automakers, steel producers and builders expanded output to meet rising demand driven by the nation's $586 billion stimulus spending. Oil imports jumped 18 percent to 19.6 million metric tons, and iron ore purchases rose 5 percent to 58.1 million tons from a month ago, the Beijing-based customs said today in a statement on its Web site. The second-largest energy user and biggest iron ore buyer spent a combined $13.8 billion on the commodities. Record lending and public-work spending in China have lifted industrial output, boosted sales at General Motors Co. and spurred a 60 percent jump in property sales. The nation's biggest refiners will boost diesel and gasoline output this month to meet demand from the auto and fishing industries, said China Petrochemical Corp., also known as Sinopec Group. "This is a very bullish number and supportive for global oil prices," said Gordon Kwan, head of regional energy research at Mirae Asset Securities Ltd. "Successive months of robust automobile sales following the implementation of the economic stimulus measures," is triggering the oil import boom, he said. Crude steel production in China, the world's biggest maker, surged 13 percent last month to 50.7 million tons, the National Bureau of Statistics also said today at a briefing in Beijing. That's the third consecutive record monthly high, according to Bloomberg data. Iron ore is used in steelmaking. "Iron ore restocking pushed up the imports and prices as the stimulus package drives up steel demand," said Helen Wang, a Shanghai-based analyst with DBS Vickers Hong Kong Ltd., "Steelmakers have the motivation to ramp up production with higher steel prices. "Benchmark Chinese steel prices have soared 30 percent since April, and Baosteel Group Corp., China's largest steelmaker, can't meet "explosive" demand, JPMorgan Chase & Co. said last week. The steel revival has hampered China's ability to bargain down iron ore prices paid to Rio Tinto Group, Vale SA and BHP Billiton Ltd., and indicates imports of the raw material will keep rising. (Bloomberg)
EGT b/a .30/30 in PM? Sweet!~
NEP is on fire here. Going for double digits over the next few days....extremely undervalued. Low floater just starting to get noticed.
Looks like EGT run to .30+ starting here. A break of .22 confirms the reversal. Q2 earnings should be very good. Tick, tock....
EGT volume alert here with about 200K shares traded in the last 10 minutes. Someone is accumulating today in anticipation of a move next week (ahead of earnings). This one is long overdue for a big rally.
Woohooo! How many "Government" minimum wage jobs were created in July? Is this jobless report accurate or will the trend continue and we will see it revised in 3 weeks to reflect the correct #'s? Inquiring minds want to know....
EGT looks to be extremely undervalued here @ .18. They are clearly turning things around with increasing their revenues and restructuring their debt. At this pps, EGT looks to be priced for bk and is not indicative of the positive steps they have taken recently to improve their financial situation.
EGT was trading @ $3/share not too long ago. While I don't see them returning to that level anytime soon, the potential for a run to .50+ seems highly likely once more people realize the steps this company is taking to improve their bottom line.
The CEO has stated that EGT is targeting the 3rd Q or 4th Q to break even. That alone warrants a pps > the current level.
I think that EGT has huge potential for a big run in the near term. The Q2 report is due out on 8/13 (and should be a very good one) and will most likely be a catalyst for the big move. AJMHO & gltu
EGT - Nice bid support here @ .185. Looks like today may be the day we see the .19 break & start of the run. gltu
Fringe, what are your thoughts on EGT T/A? Looks to be setting up nicely here. tia
$1 for EGT is not out of the question IMO. This ran to .37 on no news and during a time when everyone thought that gambling related stocks were all going under.
EGT is now positioning themselves to be EBITDA positive by the end of 09'. Not an easy feat during this recessionairy period.
Let's not forget that EGT was trading around $3/share not long ago before the market meltdown. This is a turnaround play and a bargain (gift) under .20 IMO.
EGT setting up for a big run IMO. As we saw with the run a couple of months ago to the .30's, it won't take much volume to get this one moving again. Insiders hold 1/2 the OS. The Q report due out in August will show that EGT is doing a great job reducing their debt (restructuring of debt with favorable terms to EGT) & increasing revenue (net wins per day).
EGT Mgmt stated recently that they "expect to turn adjusted EBITDA positive in the third or fourth quarter of 2009".
EGT @ .17 is a steal IMO. This pps is priced for BK. EGT is far from BK, is a big board stock & is on the right track to be profitable within the next 3-6 months.
One of the best bargains I have seen out there with multi-bagger potential. These prices won't last.
I expect to see EGT trading @ .50+ within the next few months. Great time to accumulate down here.
This one is still under the radar but won't be for long after the August Q report comes out IMHO.
I picked up some EGT @ .17. This should see at least mid to high .20's within the next week or so (leading up to earnings).
If earnings are as good as I suspect, this could see .30+ post earnings announcement. gltu
SQNM setting up for a big bounce here on options expiration. Should be back to $5+ next week IMO.
SQNM on watch today for a $5.36 break today. Going to be a big week for this one IMO.
SQNM will be a runaway train on a $5.36 break IMO. Another biotech that has had huge volume the last week and looks to break out big soon.
In SQNM @ 4.95. Looking very strong today. Volume has been unreal the last few days. Something is up.
Thanks for the update on EGT breen. EGT definitely does look interesting here with a .50 BV (that doesn't include the 400 more machines they plan to add this year). This should be an easy double, from here, with some patience IMHO.
Blue skies above for EGT once it breaks the .23 wall.
Nice .20 break for EGT. Looks ready for a big move here. Bring on the Golden cross....
Once upon a time in a village, a man appeared and announced to the villagers that he would buy monkeys for $10 each. The villagers, seeing that there were many monkeys around, went out to the forest and started catching them.
The man bought thousands at $10 and as supply started to diminish, the villagers stopped their effort. He further announced that he would now buy at $20. This renewed the efforts of the villagers and they started catching monkeys again.
Soon the supply diminished even further and people started going back to their farms. The offer increased to $25 each and the supply of monkeys became so little that it was an effort to even see a monkey, let alone catch it!
The man now announced that he would buy monkeys at $50! However, since he had to go to the city on some business, his assistant would now buy on behalf of him.
In the absence of the man, the assistant told the villagers; "Look at all these monkeys in the big cage that the man has collected. I will sell them to you at $35 and when the man returns from the city, you can sell them to him for $50 each."
The villagers rounded up all their savings and bought all the monkeys.
They never saw the man or his assistant again, only monkeys everywhere!
Now you have a better understanding of how the stock market works.
You're welcome.
Look at the chart. EGT was trading pretty consistently around $2/share before the "recession". I'm looking for $1+ short term with a long term return back to $2+. AJMHO
EGT running into the close here...
It's still early in PM. I think that EGT will open @ .25. Looking very strong. gltu
EGT .19 break and run....Sweet!
Locked and loaded with EGT. Looks ready for a big move.
Agreed. EGT was trading @ $5 last year. I'm accumulating big time down here @ .18.
Here is a nice write-up on EGT:
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=38109864
With insiders holding more than 1/2 the OS, this should go big real soon IMO. gltu
Picked up some EGT here. Looks ready for a big move.
It's only a matter of time before Joey puts his foot in his mouth and pisses off the Serbians. AJMHO
It sure does take a 'nitwit' to figure out this market.....:)